Test the CAGIB score to predict death in cirrhosis with bleeding
Part of Digestive system clinical trials.
This study checks whether a score called CAGIB can accurately predict the risk of dying during the hospital stay for people with cirrhosis who have sudden bleeding in the digestive tract. It may help doctors identify who needs the most urgent care and monitor outcomes more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver cirrhosis (scarring of the liver).
- You are an adult age 18 or older.
- You were admitted for sudden digestive-tract bleeding (vomiting blood, black stools, and/or bloody stools).
- You have enough information to calculate your Child-Pugh, MELD, and CAGIB score parts.
- Your hospital outcome (whether the outcome can be tracked) is available and can be evaluated.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at simple body measurements (like blood pressure and heart rate) to help predict how well people with cirrhosis (liver damage) who are having bleeding in their stomach or intestines will recover. It may help doctors make better treatment decisions.
This study checks how well a risk score predicts the need for treatment in patients with upper gastrointestinal bleeding (bleeding in the stomach or esophagus). It may help doctors decide if you need urgent care.
This trial is testing if a special blood test called ROTEM can help doctors predict the risk of bleeding after high-risk procedures in people with cirrhosis. It aims to improve safety and guide treatment decisions.
This study aims to create a tool that helps doctors predict if a patient with upper gut bleeding (not from veins) will rebleed while still in the hospital. It uses information from your hospital stay to better understand your risk and improve care.
This study checks whether a simple blood test score (called HALP) can help predict which people with upper gastrointestinal bleeding are more likely to have serious complications. The goal is to find patients who need closer monitoring or quicker treatment.
This study is comparing new scoring systems to better predict outcomes for people hospitalized with serious liver cirrhosis complications. It may help doctors understand which patients need more intensive care.
Hear when a new Gastrointestinal Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.